Literature DB >> 11479010

Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene.

T Murakami1, I Nagano, T Hayashi, Y Manabe, M Shoji, Y Setoguchi, K Abe.   

Abstract

A replication-defective recombinant adenoviral vector containing E. coli lacZ gene was injected into the gastrocnemius muscles of transgenic mice carrying mutant Cu/Zn superoxide dismutase (SOD1) gene and non-transgenic wild-type mice at 40 weeks of age. After 60 and 90 h of the injection, lacZ staining was observed at the distal ends of the sciatic nerves in both mice groups, with the number and the distances greatly reduced in the transgenic mice. Mean velocities of retrograde transport for lacZ was estimated to be 2.1 and 0.05 mm/24 h in non-transgenic and transgenic mice, respectively. These results indicate that the retrograde axonal transport of foreign gene product is impaired in the mice model for familial amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479010     DOI: 10.1016/s0304-3940(01)02036-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Cytoplasmic dynein mediates adenovirus binding to microtubules.

Authors:  Samir A Kelkar; K Kevin Pfister; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Lentiviral vector mediates exogenous gene expression in adult rat DRG following peripheral nerve remote delivery.

Authors:  Ping Yang
Journal:  J Mol Neurosci       Date:  2012-02-09       Impact factor: 3.444

3.  PATHOLOGIES OF AXONAL TRANSPORT IN NEURODEGENERATIVE DISEASES.

Authors:  Xin-An Liu; Valerio Rizzo; Sathyanarayanan V Puthanveettil
Journal:  Transl Neurosci       Date:  2012-12-01       Impact factor: 1.757

Review 4.  Tetanus toxin C-fragment: the courier and the cure?

Authors:  Janne M Toivonen; Sara Oliván; Rosario Osta
Journal:  Toxins (Basel)       Date:  2010-10-29       Impact factor: 4.546

Review 5.  Multidisciplinary Interventions in Motor Neuron Disease.

Authors:  U E Williams; E E Philip-Ephraim; S K Oparah
Journal:  J Neurodegener Dis       Date:  2014-11-18

Review 6.  Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Eleni Christoforidou; Greig Joilin; Majid Hafezparast
Journal:  J Neuroinflammation       Date:  2020-04-28       Impact factor: 8.322

Review 7.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

Review 8.  Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.

Authors:  Hristelina Ilieva; Magdalini Polymenidou; Don W Cleveland
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

9.  An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans.

Authors:  Jiou Wang; George W Farr; David H Hall; Fei Li; Krystyna Furtak; Lars Dreier; Arthur L Horwich
Journal:  PLoS Genet       Date:  2009-01-23       Impact factor: 5.917

10.  Gene therapy for neuropathic pain using dorsal root ganglion-targeted helper-dependent adenoviral vectors with GAD67 expression.

Authors:  Nobuhiro Ogawa; Tomoya Terashima; Kazuhiro Oka; Lawrence Chan; Hideto Kojima
Journal:  Pain Rep       Date:  2018-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.